Items where Author is "Feuring-Buske, M."
![]() | Up a level |
Other
Fuchs, M. and Wongso, D. and Pluetschow, A. and Feuring-Buske, M. and Hertenstein, B. and Hoeffkes, H. G. and Vogelhuber, M. and von Tresckow, B. and Biersack, H. and Link, H. and Topp, M. S. and Fischer, N. and Bredenfeld, H. and Sasse, S. and Behringer, K. and Boell, B. and Borchmann, P. and Engert, A. (2014) FINAL ANALYSIS OF A RANDOMIZED PHASE II STUDY WITH PREDNISONE, VINBLASTINE, DOXORUBICIN, AND GEMCITABINE IN PATIENTS WITH EARLY UNFAVORABLE HODGKIN LYMPHOMA -PVAG-14 PILOT-. FERRATA STORTI FOUNDATION, PAVIA.
Fuchs, M. and Wongso, D. and Pluetschow, A. and Feuring-Buske, M. and Hertenstein, B. and Hoeffkes, H. -G and Vogelhuber, M. and von Tresckow, B. and Biersack, H. and Link, H. and Topp, M. S. and Fischer, N. and Bredenfeld, H. and Sasse, S. and Behringer, K. and Boell, B. and Borchmann, P. and Engert, A. (2014) Final analysis of a randomized phase II trial with prednisone, vinblastine, doxorubicin, and gemcitabine in patients with early unfavorable Hodgkin lymphoma -PVAG-14 pilot-. KARGER, BASEL.
Boell, B. and Pluetschow, A. and Eichenauer, D. A. and Thielen, I and von Tresckow, B. and Atta, J. and Pfreundschuh, M. and Feuring-Buske, M. and Vogelhuber, M. and Soekler, M. and Fuchs, M. and Engert, A. and Borchmann, P. (2014) German Hodgkin Study Group Phase I trial of Doxorubicin, Vinblastine, Dacarbazine, and Lenalidomide (AVD-Rev) for elderly Hodgkin Lymphoma patients. KARGER, BASEL.

